What this study is
This rigorous randomized controlled trial will evaluate the efficacy and acceptability of a preemptive, telehealth intervention (tele-ImPACT) in a large, representative sample of infant siblings of autistic children, who are known to be at high likelihood of receiving a future diagnosis of autism and/or developmental language disorder (HL-Sibs). If our hypotheses are supported, this innovative and interdisciplinary study will provide empirical support for a novel approach to treatment that is theoretically motivated and developmentally informed, as well as accessible for and acceptable to families, and will lend new insights into the developmental windows in which, mechanisms by which, and subgroups for which the treatment works. Such findings would have strong implications for research, policy, theory, and practice in young children at risk for autism and/or language disorder.
What's being tested
- tele-ImPACT
Intervention · BEHAVIORAL
Participants will receive 12 weeks of Project ImPACT intervention as delivered via Telehealth
Study details
- Official title
- Sibwatch: Optimizing Intervention Options for Infants and Toddlers With a High Likelihood of Social Communication Delays and Language Disorder
- Sponsor
- University of Texas at Austin
- Conditions
- Autism Sibling
- Enrolling
- 140 people
- Starts
- 2026-04-01
- Est. completion
- 2032-03-31
- Design
- Double-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 6 Months – 24 MonthsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Chronological age between 6-24 months
- Has at least one older biological sibling diagnosed with autism
You can't join if
- Adverse neurological history
- Primary sensory deficit (hearing or visual impairment)
- Pre-term birth (gestation <37 weeks)
- Pre-existing diagnosis of autism or language delay
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 open- Recruiting
Little Longhorn Lab
Austin, Texas, United States
- Lauren Hampton, PhD · Contact512-471-2090sibwatch@austin.utexas.edu
Recruiting
Study team
Sponsor
University of Texas at Austin
Study ID STUDY00006726
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.